Genky DrugStores Co., Ltd.
Genky DrugStores Co., Ltd. (9267.T) Stock Competitors & Peer Comparison
See (9267.T) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 9267.T | ¥4,695.00 | +3.87% | 140B | 19.86 | ¥231.88 | +0.28% |
| 3088.T | ¥3,313.00 | +3.66% | 1.3T | 24.05 | ¥133.89 | +1.37% |
| 3349.T | ¥9,749.00 | +2.00% | 755.6B | 24.37 | ¥391.26 | +0.73% |
| 7649.T | ¥3,805.00 | +1.77% | 685B | 16.60 | ¥228.08 | +0.92% |
| 3391.T | ¥11,310.00 | +0.18% | 546.5B | 33.37 | ¥336.23 | +2.38% |
| 9989.T | ¥4,629.00 | +0.89% | 536.3B | 17.45 | ¥262.82 | +2.84% |
| 3141.T | ¥2,579.50 | +0.35% | 533.9B | 29.25 | ¥87.86 | +1.40% |
| 3549.T | ¥4,141.00 | +0.51% | 411.1B | 23.33 | ¥174.28 | +0.34% |
| 3148.T | ¥3,510.00 | -0.14% | 224.8B | 14.33 | ¥242.84 | +1.95% |
| 9627.T | ¥6,138.00 | +1.61% | 211.7B | 22.40 | ¥269.43 | +1.33% |
Stock Comparison
9267.T vs 3088.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 3088.T has a market cap of 1.3T. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 3088.T trades at ¥3,313.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 3088.T's P/E ratio is 24.05. In terms of profitability, 9267.T's ROE is +0.14%, compared to 3088.T's ROE of +0.11%. Regarding short-term risk, 9267.T is less volatile compared to 3088.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9267.T.Check 3088.T's competition here
9267.T vs 3349.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 3349.T has a market cap of 755.6B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 3349.T trades at ¥9,749.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 3349.T's P/E ratio is 24.37. In terms of profitability, 9267.T's ROE is +0.14%, compared to 3349.T's ROE of +0.12%. Regarding short-term risk, 9267.T is less volatile compared to 3349.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9267.T.Check 3349.T's competition here
9267.T vs 7649.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 7649.T has a market cap of 685B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 7649.T trades at ¥3,805.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 7649.T's P/E ratio is 16.60. In terms of profitability, 9267.T's ROE is +0.14%, compared to 7649.T's ROE of +0.11%. Regarding short-term risk, 9267.T is more volatile compared to 7649.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9267.T.Check 7649.T's competition here
9267.T vs 3391.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 3391.T has a market cap of 546.5B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 3391.T trades at ¥11,310.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 3391.T's P/E ratio is 33.37. In terms of profitability, 9267.T's ROE is +0.14%, compared to 3391.T's ROE of +0.06%. Regarding short-term risk, 9267.T is more volatile compared to 3391.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9267.T.Check 3391.T's competition here
9267.T vs 9989.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 9989.T has a market cap of 536.3B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 9989.T trades at ¥4,629.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 9989.T's P/E ratio is 17.45. In terms of profitability, 9267.T's ROE is +0.14%, compared to 9989.T's ROE of +0.12%. Regarding short-term risk, 9267.T is less volatile compared to 9989.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9267.T.Check 9989.T's competition here
9267.T vs 3141.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 3141.T has a market cap of 533.9B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 3141.T trades at ¥2,579.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 3141.T's P/E ratio is 29.25. In terms of profitability, 9267.T's ROE is +0.14%, compared to 3141.T's ROE of +0.06%. Regarding short-term risk, 9267.T is more volatile compared to 3141.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9267.T.Check 3141.T's competition here
9267.T vs 3549.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 3549.T has a market cap of 411.1B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 3549.T trades at ¥4,141.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 3549.T's P/E ratio is 23.33. In terms of profitability, 9267.T's ROE is +0.14%, compared to 3549.T's ROE of +0.13%. Regarding short-term risk, 9267.T is less volatile compared to 3549.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9267.T.Check 3549.T's competition here
9267.T vs 3148.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 3148.T has a market cap of 224.8B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 3148.T trades at ¥3,510.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 3148.T's P/E ratio is 14.33. In terms of profitability, 9267.T's ROE is +0.14%, compared to 3148.T's ROE of +0.11%. Regarding short-term risk, 9267.T is more volatile compared to 3148.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9267.T.Check 3148.T's competition here
9267.T vs 9627.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 9627.T has a market cap of 211.7B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 9627.T trades at ¥6,138.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 9627.T's P/E ratio is 22.40. In terms of profitability, 9267.T's ROE is +0.14%, compared to 9627.T's ROE of +0.07%. Regarding short-term risk, 9267.T is less volatile compared to 9627.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9267.T.Check 9627.T's competition here
9267.T vs 3341.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 3341.T has a market cap of 117.1B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 3341.T trades at ¥3,915.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 3341.T's P/E ratio is 84.14. In terms of profitability, 9267.T's ROE is +0.14%, compared to 3341.T's ROE of +0.02%. Regarding short-term risk, 9267.T is more volatile compared to 3341.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9267.T.Check 3341.T's competition here
9267.T vs 219A.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 219A.T has a market cap of 80.3B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 219A.T trades at ¥3,510.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 219A.T's P/E ratio is 88.04. In terms of profitability, 9267.T's ROE is +0.14%, compared to 219A.T's ROE of -0.10%. Regarding short-term risk, 9267.T is less volatile compared to 219A.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9267.T.Check 219A.T's competition here
9267.T vs 3034.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 3034.T has a market cap of 79B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 3034.T trades at ¥2,154.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 3034.T's P/E ratio is 15.26. In terms of profitability, 9267.T's ROE is +0.14%, compared to 3034.T's ROE of +0.09%. Regarding short-term risk, 9267.T is less volatile compared to 3034.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9267.T.Check 3034.T's competition here
9267.T vs 2664.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 2664.T has a market cap of 62.4B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 2664.T trades at ¥2,797.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 2664.T's P/E ratio is 12.82. In terms of profitability, 9267.T's ROE is +0.14%, compared to 2664.T's ROE of +0.04%. Regarding short-term risk, 9267.T is more volatile compared to 2664.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9267.T.Check 2664.T's competition here
9267.T vs 4931.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 4931.T has a market cap of 49.1B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 4931.T trades at ¥2,412.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 4931.T's P/E ratio is 21.45. In terms of profitability, 9267.T's ROE is +0.14%, compared to 4931.T's ROE of +0.11%. Regarding short-term risk, 9267.T is less volatile compared to 4931.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9267.T.Check 4931.T's competition here
9267.T vs 7679.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 7679.T has a market cap of 45.4B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 7679.T trades at ¥2,331.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 7679.T's P/E ratio is 10.61. In terms of profitability, 9267.T's ROE is +0.14%, compared to 7679.T's ROE of +0.12%. Regarding short-term risk, 9267.T is less volatile compared to 7679.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9267.T.Check 7679.T's competition here
9267.T vs 8095.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 8095.T has a market cap of 20.4B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 8095.T trades at ¥503.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 8095.T's P/E ratio is -10.32. In terms of profitability, 9267.T's ROE is +0.14%, compared to 8095.T's ROE of -0.08%. Regarding short-term risk, 9267.T is more volatile compared to 8095.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9267.T.Check 8095.T's competition here
9267.T vs 3417.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 3417.T has a market cap of 16.9B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 3417.T trades at ¥1,240.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 3417.T's P/E ratio is 6.40. In terms of profitability, 9267.T's ROE is +0.14%, compared to 3417.T's ROE of +0.09%. Regarding short-term risk, 9267.T is less volatile compared to 3417.T. This indicates potentially lower risk in terms of short-term price fluctuations for 9267.T.Check 3417.T's competition here
9267.T vs 4350.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 4350.T has a market cap of 14.5B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 4350.T trades at ¥500.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 4350.T's P/E ratio is 11.51. In terms of profitability, 9267.T's ROE is +0.14%, compared to 4350.T's ROE of +0.08%. Regarding short-term risk, 9267.T is more volatile compared to 4350.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9267.T.Check 4350.T's competition here
9267.T vs 3544.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 3544.T has a market cap of 11.6B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 3544.T trades at ¥840.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 3544.T's P/E ratio is 19.05. In terms of profitability, 9267.T's ROE is +0.14%, compared to 3544.T's ROE of +0.07%. Regarding short-term risk, 9267.T is more volatile compared to 3544.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9267.T.Check 3544.T's competition here
9267.T vs 4890.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 4890.T has a market cap of 9.6B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 4890.T trades at ¥375.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 4890.T's P/E ratio is 47.53. In terms of profitability, 9267.T's ROE is +0.14%, compared to 4890.T's ROE of +0.15%. Regarding short-term risk, 9267.T is more volatile compared to 4890.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9267.T.Check 4890.T's competition here
9267.T vs 2796.T Comparison August 2025
9267.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9267.T stands at 140B. In comparison, 2796.T has a market cap of 5.7B. Regarding current trading prices, 9267.T is priced at ¥4,695.00, while 2796.T trades at ¥501.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9267.T currently has a P/E ratio of 19.86, whereas 2796.T's P/E ratio is -6.95. In terms of profitability, 9267.T's ROE is +0.14%, compared to 2796.T's ROE of -0.11%. Regarding short-term risk, 9267.T is more volatile compared to 2796.T. This indicates potentially higher risk in terms of short-term price fluctuations for 9267.T.Check 2796.T's competition here